InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Browse the full record of transactions filed by de Garidel Marc, Chairman & CEO. Insider active across 1 companies, notably CinCor Pharma, Inc.. In total, 2 disclosures have been recorded. Total volume traded: €353k. The latest transaction was filed on 11 January 2022 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations2 total
€176,51612,500 shares@ €14.1213100.0% of flow
Common Stock
SEC:0001209191-22-003186·
Ideal exit: 8 Oct 2022 (T+270)
€176,51612,500 shares@ €14.121350.0% of flow
Common Stock
SEC:0001209191-22-003186:0·
Ideal exit: 8 Oct 2022 (T+270)
2 of 2 declarations
About de Garidel Marc
Marc de Garidel is the Chief Executive Officer of CinCor Pharma, Inc. In this role, he leads the company's operations and oversees the overall strategy. His leadership is essential in guiding research and development initiatives aimed at delivering innovative solutions in the healthcare sector.
